The mechanistic basis involves ARMC12, which functions within liquid-liquid phase-separated condensates to co-activate MYC, driving the subsequent up-regulation of NUP62, NUP93, and NUP98, elevation of NPC number, and tumor progression. The gene discussed is NUP93; the disease is neoplasm.